ESC 365 - Alirocumab reduces total coronary plaque burden in patients with familial hypercholesterolaemia and no previous clinical atherosclerotic disease

ESC Professional Premium Access

Alirocumab reduces total coronary plaque burden in patients with familial hypercholesterolaemia and no previous clinical atherosclerotic disease

Session: Cardiovascular risk assessment - Biomarkers & imaging

Topic: Imaging

Speaker: Doctor T. Padro (Barcelona, ES)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Teresa Padro

Cardiovascular Program-ICCC, IR-Hospital Santa Creu i Sant Pau, CIBERCV, Barcelona (Spain)

4 presentations

1 follower

6 more presentations in this session

Characteristics of patients with lipoprotein(a) assessment: a health insurance claims database analysis

Speaker: Doctor P. Stuerzebecher (Leipzig, DE)

Time series clustering of left atrial strain curves for risk stratification in the general population

Speaker: Mr E. Ntalianis (Leuven, BE)

Quantitative cardiovascular magnetic resonance perfusion mapping as a guide for diagnosis

Speaker: Doctor E. Androulakis (London, GB)

Radial artery calcification in predicting coronary calcification and atherosclerosis burden

Speaker: Doctor Z. Ruzsa (Szeged, HU)

Coronary CT angiography derived pericoronary inflammation and bespoke cardiovascular risk prediction in the lipid clinic: beyond the calcium score

Speaker: Doctor J. Graby (Bath, GB)

Access the full session

Cardiovascular risk assessment - Biomarkers & imaging

Speakers: Doctor T. Padro, Doctor P. Stuerzebecher, Mr E. Ntalianis, Doctor E. Androulakis, Doctor Z. Ruzsa...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources